Freenome Holdings, Inc.:
Biotechnology diagnostics company utilizing its deep expertise in molecular biology with advanced computational biology and machine learning techniques; the company pioneered a comprehensive multiomics platform for early cancer detection through a routine blood draw. $160M Series B led by RA and Polaris with Perceptive T. Rowe, Roche Ventures, Kaiser Permanente, and the American Cancer Society’s BrightEdge Ventures.
Healthcare/Medical Diagnostics & Research
US - Pacific
259 East Grand Avenue
South San Francisco, CA 94080
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.